Cefdinir Powder, For Suspension
Product Images NDC 68180-722

This is a prescription drug that contains cefdinir USP, which is used to treat infections in children. The usual dosage is 14 mg/kg/day, either as a single dose or in two divided doses. The dosage depends on age, weight, and type of infection. This medicine is manufactured by Lupin Pharmaceuticals, Inc. The package contains 1.5 g of cefdinir USP. To make the suspension, add 35 mL of water to the bottle and shake well. The suspension should be stored at 20° to 25°C. The package includes full prescribing information. Keep it out of the reach of children. The reconstituted medicine should be discarded after 10 days. The bottle should be tightly closed and shaken well before each use.*

This is a medication description for Cefdinir USP suspension manufactured by Lupin Pharmaceuticals. It is recommended for use in children at a dose of 14 mg/kg/day in a single or divided doses depending on age, weight, and type of infection. The reconstitution process involves adding 35 mL of water to the powder in the bottle, shaking, and completing the suspension. This provides 60 mL of suspension with each 5mL containing 250mg of cefdinir. It is important to keep the bottle closed tightly and store the dry powder and reconstituted suspension at 20° to 25°C. Unused portions of the medication must be discarded after 10 days from the date of mixing. The accompanying literature should be consulted for full prescribing information.*

This is a description of Cefdinir for Oral Suspension USP, a medication for oral use only that contains 125 mg of cefdinir per teaspoonful (5 mL) when reconstituted with 38 mL water. The bottle contains 1.5 g of cefdinir USP and is manufactured by Lupin Limited in Mandideep, India, and distributed by Lupin Pharmaceuticals Inc. in Baltimore, MD, United States. The usual dosage for children is 14 mg/kg/day in one or two divided doses, depending on age, weight, and type of infection. After mixing, any unused portion of the suspension must be discarded within 10 days. The dry powder and the reconstituted suspension should be stored at 20° to 25°C (68° to 77°F), and the bottle should be kept tightly closed. The text also includes directions for reconstitution and a code number for manufacturing.*

This text provides instructions and information about the dosage, preparation, and storage of a medication called Cofidinir USP in the form of a suspension. The medication is meant for oral use only and should be taken in divided doses based on age, weight, and infection type. It is manufactured by Lupin Pharmaceutical, Inc. and Lupin Limited. The text also warns to keep the medication out of reach of children and to discard any unused portion after ten days.*